Ronglih Liao, PhD

Ronglih Liao is Co-Director of the Stanford Amyloid Center and Professor of Medicine at Stanford University School of Medicine. She is also a visiting Professor of Medicine at Brigham and Women's Hospital, Harvard Medical School. The major goal of her research program focuses on understanding the mechanisms that underlie the pathophysiology of heart failure and developing novel treatments to combat this process. Her laboratory has played an international leading role in the study of amyloid light chain (AL) cardiomyopathy, a rare and fatal form of cardiovascular disease.

She was the first female Council Chair (2016-2018) of AHA Basic Cardiovascular Science Council. Dr. Liao has served numerous major leadership roles, with service to national and international societies, committees, and funding agencies and as a committee member or reviewer.

Moreover, Dr. Liao has continued her competitive independent investigation, under direct research funding from the NIH continuously for over a decade. Over the years, Liao Lab has made critical contributions to the understanding of the molecule mechanisms that underlie the development of amyloid cardiomyopathy as well as the regulation of both cell fate and function in adult cardiac progenitor cells.